Optimization services for the
clinical trial supply chain

Access the best optimization services the industry can offer and reduce your drug needs and budgets by 20-40% (compared to forecasting solutions) while avoiding any risks of missed dispensing.

N-SIDE delivers optimized supply plans, drug waste levels, depot shipment recommendations, and IRT configuration, along with reliable and robust forecasts. We also provide a monitoring dashboard to anticipate any risk and machine learning to adapt your supply strategy to real-time events.

The earlier the optimization, the larger the impact. Even with just a protocol outline or draft, you can benefit from the power of optimization.

N-SIDE will help you optimize your trial and bring a supply chain perspective to trial design. We’ll assess the impact of protocol design, kit design, country selection, network design, vendor specifications, and more. Through KPIs and factual support, N-SIDE will help Supply reach an agreement with ClinOps on a trial design that does not make the supply chain a bottleneck and achieves a faster, less risky, and less wasteful trial.

These services typically reduce drug needs and budgets by up to 60%.

An important release is delayed. There’s a global shortage of a comparator. Recruitment went faster than planned. Pandemics, politics, or natural disasters are putting your patients’ supply at risk.

If you encounter a risk of drug stockout or missed dispensing in your trial, N-SIDE can help. Within days, we’ll identify and quantify the risk then propose innovative solutions to mitigate it, ensuring smooth trial continuity and zero patient impact.

N-SIDE experts can help you optimize all steps of manufacturing and drug flow (e.g. quantities, timing, allocation) across the clinical supply chain, from formulation to packaging and beyond.

Adapt your manufacturing to real-time events, manage risks, and plan up to 10 years out. If you have scarce resources, a complex manufacturing network, or a large amount of products, this service delivers valuable visibility, control, and waste reduction.

Many important decisions need to be made in R&D manufacturing/CMC. Outsourced or in-house manufacturing? Which network should I use? What’s the optimal stability plan? What’s the best way to handle scale-up to Phase 3 and the transition to commercial?

N-SIDE clinical manufacturing specialists will use our software to optimize the most important strategic decisions for your program, delivering important cost savings and waste reduction.

Transitioning to a digital, data-driven clinical supply chain requires more than technology; it demands adaptation throughout the business.

N-SIDE experts will support your change management journey, starting with a clear vision associated with measurable added value for R&D efficiency.

Keeping this purpose in mind, N-SIDE will help your teams take advantage of advanced analytics to become a truly data-driven organization.

By optimizing manufacturing for the entire clinical program and optimizing supply for each individual trial, we can typically free up to 50% of the initially planned quantities and accelerate time to commercialization by 2-6 months.

We accomplish this by reducing drug needs at the trial level and limiting manufacturing waste. That enables us to either cancel production lots and re-allocate the resources to new programs, or to re-invest that drug into increased sites and recruitment speed.